<?xml version="1.0" encoding="UTF-8"?>
<ref id="hep41482-bib-0006">
 <label>6</label>
 <mixed-citation publication-type="journal" id="hep41482-cit-0006">
  <string-name>
   <surname>Feld</surname>
   <given-names>JJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Jacobson</surname>
   <given-names>IM</given-names>
  </string-name>, 
  <string-name>
   <surname>Hézode</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Asselah</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Ruane</surname>
   <given-names>PJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Gruener</surname>
   <given-names>N</given-names>
  </string-name>, et al. 
  <article-title>Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection</article-title>. 
  <source xml:lang="en">N Engl J Med</source>
  <year>2015</year>;
  <volume>373</volume>:
  <fpage>2599</fpage>‐
  <lpage>2607</lpage>.
  <pub-id pub-id-type="pmid">26571066</pub-id>
 </mixed-citation>
</ref>
